Results 31 to 40 of about 1,502,489 (240)
Visual BOLD Response in Late Blind Subjects with Argus II Retinal Prosthesis.
PLoS Biology, 2016 Retinal prosthesis technologies require that the visual system downstream of the retinal circuitry be capable of transmitting and elaborating visual signals.
E Castaldi +5 more
doaj +1 more source
Healthy aims: developing new medical implants and diagnostic equipment [PDF]
, 2008 Healthy Aims is a €23-million, four-year project, funded under the EU’s Information Society Technology Sixth Framework program to develop intelligent medical implants and diagnostic systems (www.healthyaims.org).
Bertsch, Arnaud +10 more
core +1 more source
Ophthalmic Surgery Lasers and Imaging Retina, 2020 BACKGROUND AND OBJECTIVE Assess fluocinolone acetonide implant (FAc) effects on diabetic macular edema (DME) retinal thickness fluctuations. PATIENTS AND METHODS A post-hoc chart review of the real-world USER study analyzed patients receiving 0.2 μg ...
C. Riemann, A. Eaton, A. Cutino
semanticscholar +1 more source
Dexamethasone Implant Migration through an Iris Coloboma
Case Reports in Ophthalmology, 2020 Ozurdex® 0.7 mg (dexamethasone 0.7 mg implant, Allergan, Dublin, Ireland), an intravitreal biodegradable implant, is indicated for cystoid macular edema due to various causes.
Yoav Glidai +2 more
doaj +1 more source
Accidental intralenticular dexamethasone intravitreal implant with the resolution of macular oedema in central retinal vein occlusion [PDF]
, 2016 No abstract ...
Abdolrahimzadeh, Solmaz +3 more
core +1 more source
Case Reports in Ophthalmology, 2013 Purpose: To report a case of rhegmatogenous retinal detachment with a high risk of proliferative vitreoretinopathy (PVR) effectively treated with episcleral surgery and an intravitreal dexamethasone 0.7-mg implant.
Michele Reibaldi +7 more
doaj +1 more source
Intravitreal injection of Ozurdex(®) implant in patients with persistent diabetic macular edema, with six-month follow-up [PDF]
, 2016 AIM: To evaluate the efficacy of intravitreal dexamethasone injections in diabetic macular edema (DME). METHODS: A 700 μg slow-release intravitreal dexamethasone implant (Ozurdex®) was placed in the vitreal cavity of 17 patients (19 eyes) affected ...
Bottone, A +8 more
core +2 more sources
Designing artificial senses: steps from physiology to clinical implementation
Swiss Medical Weekly, 2019 Our senses are the main information channels through which we perceive and interact with the world. Consequently, the physical and social functioning of patients suffering from severe sensory disabilities is limited on several levels.
Angélica Pérez Fornos +3 more
doaj +1 more source
To study the effect of intravitreal ozurdex implant in cases of retinal vein occlusion
Kerala Journal of Ophthalmology, 2022 Introduction: Retinal vein obstruction is one of the leading causes of severe vision impairment and blindness with treatment options mainly including laser, vascular endothelial growth factors, and steroids.
Shailender K Chaudhary +4 more
doaj +1 more source
Beyoglu Eye Journal, 2017 The Argus II Retinal Prosthesis System (Second Sight Medical Products, Inc., Sylmar, CA, USA) is the first US Food and Drug Administration-approved retinal implant.
İrfan Perente +2 more
doaj +1 more source